ALMKT logo

Mauna Kea Technologies SA Stock Price

ENXTPA:ALMKT Community·€18.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ALMKT Share Price Performance

€0.19
0.09 (91.20%)
€0.19
0.09 (91.20%)
Price €0.19

ALMKT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk and slightly overvalued.

4 Risks
1 Reward

Mauna Kea Technologies SA Key Details

€8.2m

Revenue

€1.0m

Cost of Revenue

€7.1m

Gross Profit

€17.5m

Other Expenses

-€10.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Apr 22, 2026
-0.11
87.33%
-127.03%
-109.6%
View Full Analysis

About ALMKT

Founded
2000
Employees
61
CEO
Alexandre Loiseau
WebsiteView website
www.maunakeatech.com

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporated in 2000 and is headquartered in Paris, France.

Recent ALMKT News & Updates

Recent updates

No updates